Patient Reported Outcomes/Survivorship
AMA PRA Category 1 Credits 1.00
CAMPEP Credits: 1.00
MDCB Credits: 1.00
Erin Gillespie, MD, MPH
University of Washington-Fred Hutchinson Cancer Center
Seattle, WASHINGTON
Patient reported outcomes (PROs) are a key component of evaluating cancer therapy. For clinical trialists, the proper design, implementation and evaluation of patient reported outcomes is critical for designing studies that will impact and inform daily practice. A patient directed survey that is not well designed or selected could lead to wasted effort and unforeseen challenges. For clinicians, understanding how patient reported outcomes complement physician and provider reported outcomes, as well as pitfalls of evaluating patient reported outcomes is important. As well, PROs can be used to trigger clinical intervention and support. This session will provide four key aspects of patient reported outcomes: The methodology of designing PROs, issues in the implementation of PROs in clinical trials, how PROs can be an intervention, and how to interpret PROs in clinical trials. This proposal has been generated by ASTRO Science Education and Program Development (SEPD) Committee members and reflects the inclusion of scientific content and new scientific advances in the field.
Speaker: Erin Gillespie, MD, MPH – University of Washington-Fred Hutchinson Cancer Center
Speaker: Minh Tam Truong, MD, MBA, MBBS, FASTRO – Boston University School of Medicine
Speaker: Deborah Bruner, PhD, RN, FAAN – Nell Hodgson Woodruff School of Nursing
Speaker: Erin Gillespie, MD, MPH – University of Washington-Fred Hutchinson Cancer Center
Speaker: Erin Gillespie, MD, MPH – University of Washington-Fred Hutchinson Cancer Center